Health & Fitness
Wed, April 11, 2012
NEW ORLEANS--([ BUSINESS WIRE ])--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC announce that KSF has commenced an investigation into ViroPharma Inc. (NASDAQ: VPHM). ViroPharma shares fell over 21.5%, after the Company revealed that it was under investigation by the Federal Trade Commission as a result of its efforts to block generic competition for its lead product Vancocin, and after the FDA granted approval of the generic drugs. According to reports, the FTC is investigating the Company for engaging ain unfair methods of competition.a
KSFas investigation is focusing on whether ViroPharma and/or its officers and directors violated federal securities laws. If you have information that would assist KSF in its investigation, or would like to discuss your legal rights, you may, without obligation or cost to you, e-mail or call KSF Managing Partner, Lewis Kahn ([ lewis.kahn@ksfcounsel.com ]), toll free, 877-515-1850, or via cell phone any time at 504-301-7900, or KSF Director of Client Relations, Neil Rothstein, Esq. ([ neil.rothstein@ksfcounsel.com ]), toll free at 877-694-9510, or via cell phone any time at 330-860-4092.
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities class action and shareholder derivative litigation with offices in New York and Louisiana. KSF's lawyers have significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders.
To learn more about KSF, you may visit [ www.ksfcounsel.com ].